Longaeva Partners »

Medline shares owned by Longaeva Partners

Quarter-by-quarter ownership of Medline (MDLN) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Medline

Tip: Access up to 7 years of quarterly data

All positions including Medline held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medline by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $28M 635k 44.50

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Medline

Carlyle
H&F Corporate Investors X
FMR
Capital Research Global Investors
Invesco
Vanguard Group
BlackRock
Morgan Stanley
Vanguard Capital Management
Vanguard Portfolio Management
Lone Pine Capital
Henderson Group
Viking Global Investors
Massachusetts Financial Services
Baillie Gifford & Co

View all funds holding Medline